KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Invested Capital (2016 - 2020)

Historic Return on Invested Capital for Inovio Pharmaceuticals (INO) over the last 6 years, with Q3 2020 value amounting to 0.49%.

  • Inovio Pharmaceuticals' Return on Invested Capital rose 9200.0% to 0.49% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.49%, marking a year-over-year increase of 9200.0%. This contributed to the annual value of 2.38% for FY2019, which is 15400.0% down from last year.
  • Latest data reveals that Inovio Pharmaceuticals reported Return on Invested Capital of 0.49% as of Q3 2020, which was up 9200.0% from 0.6% recorded in Q2 2020.
  • Inovio Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.43% for Q3 2016, and its period low was 5.19% during Q4 2019.
  • Over the past 5 years, Inovio Pharmaceuticals' median Return on Invested Capital value was 0.8% (recorded in 2019), while the average stood at 1.11%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -41900bps in 2019, then skyrocketed by 9200bps in 2020.
  • Inovio Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.54% in 2016, then tumbled by -31bps to 0.71% in 2017, then plummeted by -41bps to 1.01% in 2018, then plummeted by -416bps to 5.19% in 2019, then surged by 91bps to 0.49% in 2020.
  • Its Return on Invested Capital stands at 0.49% for Q3 2020, versus 0.6% for Q2 2020 and 1.11% for Q1 2020.